Dr Reddy's Shares Down: Goldman Sachs Cuts Target Price On Pricey Valuation

The brokerage said the opportunity for Ozempic (Semaglutide), a prescription injection for adults with Type 2 diabetes, in Canada is likely to be lower than earlier expectations.

from NDTV Profit - Latest https://ift.tt/oIkXyTF
via xxx